NasdaqGS - Delayed Quote USD

Accolade, Inc. (ACCD)

7.89 -1.30 (-14.15%)
At close: April 26 at 4:00 PM EDT
7.96 +0.07 (+0.89%)
After hours: April 26 at 7:49 PM EDT
Key Events
Loading Chart for ACCD
DELL
  • Previous Close 9.19
  • Open 7.87
  • Bid 7.87 x 400
  • Ask 7.92 x 200
  • Day's Range 7.62 - 8.56
  • 52 Week Range 6.33 - 15.36
  • Volume 1,490,874
  • Avg. Volume 625,531
  • Market Cap (intraday) 610.746M
  • Beta (5Y Monthly) 2.08
  • PE Ratio (TTM) --
  • EPS (TTM) -1.62
  • Earnings Date Jun 27, 2024 - Jul 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 14.80

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

www.accolade.com

--

Full Time Employees

February 29

Fiscal Year Ends

Recent News: ACCD

Performance Overview: ACCD

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACCD
34.30%
S&P 500
6.92%

1-Year Return

ACCD
50.59%
S&P 500
25.26%

3-Year Return

ACCD
83.79%
S&P 500
22.00%

5-Year Return

ACCD
--
S&P 500
63.68%

Compare To: ACCD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACCD

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    610.75M

  • Enterprise Value

    622.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.51

  • Price/Book (mrq)

    1.40

  • Enterprise Value/Revenue

    1.60

  • Enterprise Value/EBITDA

    -6.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -24.09%

  • Return on Assets (ttm)

    -8.41%

  • Return on Equity (ttm)

    -21.71%

  • Revenue (ttm)

    414.29M

  • Net Income Avi to Common (ttm)

    -99.81M

  • Diluted EPS (ttm)

    -1.62

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    237.03M

  • Total Debt/Equity (mrq)

    54.15%

  • Levered Free Cash Flow (ttm)

    14.61M

Research Analysis: ACCD

Analyst Price Targets

10.00
14.80 Average
7.89 Current
18.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ACCD

Fair Value

7.89 Current
 

Dividend Score

0 Low
ACCD
Sector Avg.
100 High
 

Hiring Score

0 Low
ACCD
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ACCD
Sector Avg.
100 High
 

People Also Watch